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Abstract
The extracellular nucleotides act as neurotransmitters and signaling molecules in CNS, binding to a P2X and P2Y receptors. Their
concentration  regulates  a  cascade  of  membrane  ecto  enzymes, including the ecto-nucleotide triphosphate  diphosphohydrolases
(E-NTPDases).  In  many  neuropathological  conditions,  such  as  neuroinflammatory,  epilepsy,  depression  and  migraine,  altering  of
E-NTPDase  activity  was  observed. The  objective  of  this study was  to  investigate whether Gentiana  lutea  (G.  lutea)  extracts  affect
E-NTPDase activity and which of their constituents (loganic acid,  gentiopicroside,  isovitexin,  amarogentin and isogentisin) exert
inhibitory activity. The constituent’s concentration in the extracts was determined by ultra performance liquid chromatography coupled
with mass spectrometry (UPLC-MS). Extracts and constituents  were  tested  with E-NTPDase displayed  on  the  rat  synaptosomal 
membrane as well as by molecular docking study. Ethanol water extract (50%, v/v) exerted  significant  level  of  inhibition (52%) at 
concentration  of 200 mg mLG1. By inhibition studies with single constituents about 30% inhibition was achieved in any case, thus the
model of one substrate acting on two enzymes was used to determine IC50 values. Molecular docking study revealed amarogentin,
isovitexin and isogentisin dimer as the potent E-NTPDase inhibitors with the binding energies ranging from -9.4 to -10 kcal molG1 versus
-8.0 kcal molG1 for ATP. Presence of isogentisin only in ethanol water extracts may explain their better inhibitory acitivities. Findings of
this study are useful from the perspective of safety of products based on G. lutea  extracts, while investigated constituents belong to
secoiridoids and xanthones class of compounds could be considered as a source of potential E-NTPDase inhibitors.
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INTRODUCTION
Gentiana lutea belongs to Gentianaceae family which
comprises more than 1600 species spread in the mountain
areas of all around the world. The largest genus in the
Gentianaceae  family  is  genus  Gentiana,  containing  about
400 species and among them is G. lutea  L., which grows in the
mountains of central and Southern Europe up to the altitude
of 2500 m (Franz et al., 2005;  Struwe et al., 2002).
Secoiridoids and xanthones class of compounds which
are the main consituents in the G. lutea  root exhibit numeorus
biological activity and in terms of enzyme inhibition some of
them such as: Isogentisine, isovitexin, gentiopicroside and
amarogentin showed inhibitory effects on monoamine
oxidase type A and B, xanthine oxidase, myeloperoxidase
(MPO), aldose-reductase and topoisomerase I (Lin et al., 2002;
Osamu et al., 1978;  Akileshwari et al., 2012;  Nastasijevic et al.,
2012; Ray et al., 1996). Also, in the recent study, it was shown
that  aqueous  extract  of  G.  lutea  and  isovitexin  block
platelet-derived growth factor induced proliferation of rat
aortic muscle cells (Kesavan et al., 2013). Hepatoprotective
effects of secoiridoids, inhibitory activity toward glycogen
phoshorylase  and cyclooxygenase  1  and  2 were  also
described  (Mihailovic  et  al.,  2014;  Vaidya  et  al.,  2013;
Osamu et al., 1978; Park et al., 2010). However, in few recent
studies  it  was  demonstrated  analgesic  and anxiolytic effects
of Gentiana species as well as anticonvulsant and sedative
effects of Swertia  species, in which the most abundant
components are secoiridoids and xanthones class of
compounds (Jia et al., 2012; Tovilovic et al., 2011). Due to the
increasing number of products that contain in their
composition G. lutea extracts or extract's fractions, it is still
interesting to explore its unrevealed biological effects.
One of those important biological effects could be
inhibition  of ecto-nucleotidase  with   special   emphasis   on
E-NTPDase family of enzymes (EC 3.6.1.5) (Robson et al., 2006;
Zimmermann et al., 2012). The E-NTPDase are membrane
enzymes ubiquitious in animal cells that hydrolyze extracelular
nucleotide tri and diphosphates in the presence of millimolar
concentrations of Ca2+ and Mg2+ at extracellular pH between
7 and 8. It is known that eight different E-NTPD genes encode
members of the NTPDase protein family, so far. Four of them
(NTPDase 1, 2, 3 and 8) are extracellular membrane located
enzymes, present in different proportion at the different type
of cells (Zimmermann et al., 2012; Maliszewski et al., 1994).
Results based on immunobloting and hybridizations revealed
that in mammalian brain NTPDase  1,  2  and  3  are  expressed.
However, in the  synaptosomal  fraction  isolated  from  various
sources,  the  predominant  ATPase  activity  is  attributed  to
E-NTPDase 3 based also on immunocytochemical study
(Belcher et al., 2006).
The    E-NTPDase    isoform    3    is    ouabain    insensitive
E-NTPDase,   with   specificity   toward    ATP    that    is    about
2.5  fold   higher   than   for   ADP.   Synaptosomal   fractions,
containing    synaptosomal     membranes    beside
triphosphate/diphosphohydrolase,  display  on  their  surface
other   ectonucleotidases,    such    as    ectonucleotide
pyrophosphate/phosphodiesterases  (E-NPP),  Alkaline 
Phosphatases   (AP)  and   ecto-5’-nucleotidase  (Zimmermann,
2001; Nedeljkovic et al., 1998;  Yegutkin, 2008). Presence of
different types of ectonucleotidases on the membranes
exposed to synaptic cleft indicates their role in removing of
ATP released into synaptic cleft upon exocytosis of synaptic
vesicles (Cognato and Bonan, 2010).
There, ATP together and its ending product of hydrolysis,
adenosine act  as  neurotransmitters,  exerting  their activity
via P1  (Adenosine)  and  P2  (ATP/ADP)  receptors.  Altering  in
E-NTPDase activity was observed in many neurodegenerative
diseases, such as Parkinson's, Alzheimer's and Huntington's
diseases, then neuroinflammatory diseases such as multiple
sclerosis and also in some neuropsychiatric disorders. An
increased ATP level exhibits cytotoxic damage and
neuroinflammation in the brain tissue. Decreased NTPDase
activity leads to increased ATP levels and decreases of
adenosine concentration in epilepsy. Therefore, any
compound that influences to E-NTPDase activity and their
gene  regulation  may  be  of  importance  for  the  treatment
of  mentioned  disorders  (Burnstock,  2010;  Roszek  and
Czarnecka, 2015).
Except   of   nucleoside    analogs   and   some
polyoxometalates,  the  lack  of  specific E-NTPDase  inhibitors
is the main obstacle for development of therapeutics that
could   modulate   purinergic   signaling   (Muller  et  al.,   2006;
Al Rashida and Iqbal, 2014). Taking into account the lack of
suitable inhibitors and recent findings about effects of
secoiridoids and xanthones in the brain we decided to
examine G. lutea extracts as well as its constituents as
potential inhibitors of ecto enzymes present at the membrane
of synaptosomes.
The extracts were therefore prepared in a way that is used
in human nutrition with water and water-ethanol mixtures as
extraction solvents. The main objective of this study was to
explain whether and how G.  lutea  affect E-NTPDase based on
an investigation of enzyme inhibition  with  single  consituents
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and their mixtures. For that reasons, beside their  in  vitro
screening, the molecular docking study of consituents was
performed.
MATERIALS AND METHODS 
Chemicals:       Gentiopicroside        (5-Ethenyl-6-($-D-
glucopyranosyloxy)-5,  6-dihydro-1H,  3H-pyrano[3, 4-c] pyran-
1-one), amarogentin  (2-4aS-(4a",  5ß,  6"))-3, 3', 5-Trihydroxy-
(1,   1'-biphenyl)-2-carboxylate),       isovitexin      (6-ß-D-
Glucopyranosyl-5,          7-dyxidroxy-2-(4-hydroxyphenyl)-4H-1-
benzopyran-4-one)  were  purchased  from ChromaDex (Irvine,
USA). Loganic  acid  (1"-($-D-Glucopyranosyloxy)-6"-hydroxy-
7"-methyl-1, 4a", 5, 6, 7, 7a"-hexahydrocyclopenta[c]pyran-
4-carboxylic  acid)   were  purchased   from   Extrasynthese
(Genay,  France).   Structures   of   G.   lutea    constituents
investigated in this study are shown in Fig. 1.
Acetonitrile, 2-propanol and formic acid were HPLC grade,
obtained from J.T. Baker (Deventer, Netherlands) while, glacial
acids, also HPLC grade obtained from Fisher Scientific
(Leicestershire, UK).
Plant  material  and  extracts  preparation:  Gentiana  lutea
roots  were   purchased   from   the   Institute  of  Medicinal
Plant  Research   “Dr   Josif   Pancic”,   Belgrade,  Serbia. Five
grams   of     grounded     Gentiana     roots   were  extracted
with  ethanol   aqueous   (75,   50   and   25%   v/v)  solutions
and water in the  ratio  1:20 (w/v). Extraction with ethanol
aqueous  solutions   was   performed   at   room  temperature
for  48  h  with  occasional  shaking.  Water  extract was
prepared  from   grounded  root  suspended  in  water,
followed   by   heating  in   a   boiling   water   bath   for  10 min.
After filtering (0.45 mm  filter)  extracts  were  concentrated 
using  a   rotavapor   at   35EC   and   kept   frozen  until
analysis.
Preparation of SMP and ATPase inhibition assay: Rat
Synaptic  Plasma    Membrane   (SPM)    fraction    was   isolated
following the previously described procedure (Gray and
Whittaker, 1962). This study was approved by an Institutional
Ethics Committee. Protein concentration was determined by
the method of Markwell using bovine serum albumin as a
standard (Markwell et al., 1978). Samples of SPM were kept on
-70EC until use. Solution used in enzyme  assays were
prepared in Milli-Q water. The incubation mixture contained
1 mM MgCl2, 50 mM tris-HCl, pH 7.4 and 10 mg SPM in a final
volume of 200 mL. At first, the reaction medium containing
SPM was pre-incubated for 5 min at 37EC. Gentiana  lutea
extracts and standards were added and incubated for 20 min
(unless otherwise indicated). The assay was initiated by adding
0.1 mM ATP. Incubation lasted 10 min at 37EC and reaction
was stopped by the addition of 22 mL 3M perchloric acid. The
samples were kept on ice for 15 min before assaying and
centrifuged at 5000 g for 5 min to eliminate precipitated
protein.  Supernatant  was  used  for  the  colorimetric  assay:
80 mL aliquots were withdrawn from each of the reaction
samples  into  wells  of  a 96-well NunclonTM surface  plate
(Nunc, Roskilde, Denmark) and mixed with 20 mL of the
Malachite  Green   Reagent.   The   plate   was   incubated  for
30 min at room temperature with shaking.
The absorbance at 650 nm was determined using Wallac
Victor 1420 Multilabel Counter (Perkin-Elmer Life Science,
Waltham, MA, USA). A phosphate standard curve was
prepared  using  a   set   of   phosphate   standards  ranging  in
Fig. 1(a-e): Chemical structures of G. lutea  consituents used in this study, (a) Loganic acid, (b) Gentiopicroside, (c) Amarogentin,
(d) Isovitexin and (e) Isogentisin
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concentration from 4-40.0 µM, according to the instructions of
manufacturer. Experiments were repeated at least three times 
in  duplicate  with  different  enzyme   preparations. Control 
experiments   were   carried   out   to    correct  for non-
enzymatic   hydrolysis   by   adding  SPM  after  the reaction 
was  stopped.  Enzyme   activities  were  expressed  as 10  nmol 
Pi  minG1 mgG1 of protein. The results are expressed as a mean
percent enzyme activity compared to corresponding control
value.
Molecular docking study: The crystal structure of Rattus
norvegicus NTPDase2 used for docking study was
downloaded from a Protein Data Bank (PDB code: 4CD3)
(Zebisch et al.,  2014). The  water  molecules  and  ligand
residues were removed from the structure. The structure of
inhibitors (isogenitisin,  amarogetin,  gentiopicroside,
isovitexin and loganic acid) and  ATP  was  obtained by
quantum-chemical  calculations  at  B3LYP/6-31G** level,
using   Gaussian09   program,   while    dimeric    structures    of 
isogentisin  (1,  3-dihydroxy-7-methoxyxanthone)   were
extracted from crystal structure archived in Cambridge
Structural Databases  (CSD refcode: ABEKOI) (Evans et al., 2004;
Frisch et al., 2009). Docking preparation was done by
AutoDockTools program, while the docking study was carried
out with AutoDock Vina program (Trott and Olson, 2010). All
protein residues were kept rigid and all single ligand bonds
were set to be rotational. A  grid  box,  containing  the  whole 
 protein  was  used  to accommodate  the  ligand  to  move 
freely  during  docking run. 
Chromatography conditions for extracts separation: Waters
ACQUITY UPLC system coupled with a Photodiode Array (PDA)
detector and Acquity Triple Quadrupole Detector (TQD) with
multiprobe source of ionisation including Electrospray
Ionization (ESI) and Atmospheric Pressure Chemical Ionization
(APCI) ionisation  controlled  by  MassLynx  NT  software
(version 4.1) was used for qualitative and quantitative analysis.
Extracts as well as the gentiopicroside, amarogentin, loganic
acid and isovitexin were separated on ACQUITY UPLCTM BEH
C18 column (1.7 µm, 100×2.1 mm, Waters, USA) in gradient
mode, with the mobile phase consisting of solvent A: Mixture
of  formic   acid   and   glacial  acid  (0.9:0.1,  v/v in  water) and
B: Acetonitrile-2-propanol mixture (50:50, v/v) with column
temperature of 30EC (Aberham et al., 2007). Gradient elution
used  for  separation  of  extract’s  component  starting  with
99% A for 6 min, then from 70-40% A in the next 3 min and
from 9-11 min hold at 5% A. Spectra were recorded in the
wavelength range from 190-450 nm and chromatographic
separation was monitored at 254 nm. The eluent  flow rate
was 0.3 mL  minG1, the injection volume was 5 µL. All extracts
were standardized to a concentration of 10 mg mLG1 and
filtered through 0.22 µm nylon filter (Phenomenex) before
injection. Standards were run  under  the  same gradient
mode, in concentration range from 0.1-100 µg mLG1.
Optimisation of MS conditions was performed by direct
infusion of consituents into the mass spectrometer with a
syringe pump at flow rate of 20 µL  minG1. The source
temperature  was  held  at  135EC,  desolvation  temperature
at 350EC, desolvation gas flow was 750 L hG1 while cone gas
flow  was  25 L hG1.  The  capillary  voltage  was  set at 3.8  kV.
In order to find optimal condition for ionisation it was
performed tuning of optimal cone voltages, collision energies
(using argon as collision gas) and determination of precursor
and product iones for all tested constituents. The parameters
used for ionization were optimized manually and by
IntellyStart in both positive and negative ESI mode. Some of
them were already used in the recent study (Lin et al.,  2015).
Acquisition of data were done in MS scan and Multi Reaction
Monitoring (MRM) mode, in both  ESI  positive  and  negative 
polarity, with  dwell  time  of 25 m sec as well as with PDA
detection.
RESULTS
Qualitative and quantitative analysis of G. lutea extracts: In
order to perform the qualitative  and  quntitative  analysis  of
G. lutea extracts and to determine the content of its selected
constituents  (amarogentin,  isovitexin,  gentiopicroside,
loganic acid and isogentisine), UPLC method combined with
a   PDA   and   TQD   was   performed.   The   UPLC-PDA
chromatograms of G.  lutea  water and alcohol water extracts
are presented in Fig. 2a. The characteristic absorption spectra
of compounds detected in extracts as well as chromatograms
and spectra of pure compounds are given in Supplementary
material  (Fig.  S1).  Elution  method  used  for  UPLC
chromatography of extracts combined with acquity BEH
column, enabled good separation of G. lutea  consituents
within 11 min of analysis. Mass spectrometry analysis of
extracts and constituents was performed in negative ion
mode, used for  gentiopicroside,  isovitexin and  amarogentin
analysis while the positive ion mode was used in the analysis
of loganic acid and identification  of  isogentisin. Characteristic
275
Int. J. Pharmacol., 12 (4): 272-289, 2016
Fig. 2(a-b): (a) UPLC-PDA chromatograms of G. lutea  extracts (water and 25, 50 and 75% ethanol-water) and (b) UPLC-MS MRM
chromatograms, 1: Loganic acid, 2: Gentiopicroside, 3: Isovitexin, 4: Amarogentin and 5: Isogentisin
MRM chromatograms of the constituents used in qualitative
and quantitative analysis of extracts are shown in Fig. 2b.
Qualitative analysis was performed by comparison of
retention times of standards, their MRM  chromatograms  and
276
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Table 1: The parameters used in mass spectrometry analysis of G. lutea extracts in MRM mode
Compound Empirical formula Rt (min) Detected molecular ions/adducts MRM m/z* Cone V (V)** Coll. E (eV)** ESI mode
Loganic acid C16H24O10 3.0 (M+Na)+ 399.41>202.97 44 22 +
Gentiopicroside C16H20O9 3.74 (M-H+HCOOH)G 401.11>179 20 12 -
Isovitexin C21H20O10 5.15 (M-H) 431.10>311 45 20 -
Amarogentin C29H30O13 6.79 (M-H)G 585.00>227 60 12 -
Isogentisin C14H10O5 10.07 (M+H)+ 259.00>213 50 35 +
*MRM: Multi reaction monitoring with m/z of parent ion and product ions and **Cone voltage and collision energies
Table 2: Abundance of G. lutea  constituents in extracts. All experiments were
done in triplicates and results are expressed as Mean±SD
*G. lutea 25% 50% 75% 
constituents Water ethanol ethanol ethanol
Loganic acid 0.98±0.13 0.30±0.07 0.84±0.02 0.64±0.04
Gentiopicroside 2.53±0.27 0.95±0.09 2.50±0.31 1.65±0.02
Isovitexin 0.004±0.001 0.003±0.001 0.022±0.003 0.011±0.002
Amarogentin 0.014±0.003 0.025±0.002 0.032±0.001 0.041±0.006
*Abundances of constituents are expressed as percentages, calculated on dry
matter of G.  lutea  extracts
absorption spectra with corresponding peaks found in
chromatograms of extracts. The retention times of selected
constituents as well as the parameters used for the mass
spectrometry analysis of mentioned compounds in the MRM
mode are presented in the Table 1. Total Ion Current (TIC) and
MRM chromatograms of standards and extracts are given in
Supplementary material (Fig. S2).
Applied conditions used for UPLC-TQD analysis of the
extracts in MRM mode gave parent ions which are either
protonated and deprotonated molecular  ions  or  sodium  and
formic acid adducts. Abundance of constituents determined
in this study are comparable with those obtained in the
previous studies (Aberham et al., 2007;  Mustafa et al., 2015).
The abundance of selected G. lutea   constituents  is  shown in
the Table 2. While, gentiopicroside and loganic acid were
found in all extracts as the most abundant constituents, the
presence of isogentisin, amarogentin and isovitexin are
dependent on extraction procedure.
Thus, the differences between results obtained in this
study compared with previous  studies  could  be explained
not only by different species (subspecies) used for extract
preparation (in this study G.  lutea  ssp., symphyandra) but also
with solvents used for extractions, since water and alcohol
water mixtures are more polar than 100% methanol. However,
the  most  obvious  difference among extracts  is the  presence
of isogentisin, preferebly in alchohol water extracts, especially
in 50 and 75% (v/v) extracts (Fig. 2a, b). 
Inhibition of E-NTPDase: Before the testing of the interaction
between the selected G.  lutea   constituents   and   E-NTPDase,
Fig. 3: Inhibition  of  E-NTPDase  in  the  presence  of 100 and
200  µg  mLG1  G.  lutea   water  and  ethanol-aqueous
(25, 50 and 75%) extracts. The results present the mean
values, obtained from two experiments performed in
duplicate
the enzyme was exerted to 100 and 200 mg mLG1  of water
and ethanol (25, 50 and 75%) extracts in the reaction mixture.
The working solutions were prepared in water to avoid the
enzyme inhibition by organic solvents, i.e., methanol, since in
our preliminary experiment its 2% content in water (v/v)
inhibits E-NTPDase activity by 24.82%, confirmed also in
previous study (Rico et al., 2006). The percent of enzyme
inhibition in the presence of selected G.  lutea  extracts is
shown in Fig. 3.
The results indicated that the significant enzyme
inhibition (about 35-50%)  was achieved  in  the  presence of
200 mg mLG1 of G. lutea  extracts. In order to elucidate the
contribution of each constituent to, alteration of enzyme
activity obtained  with extracts, E-NTPDase  was  exposed to
the single constituents and their synthetic mixtures. Thus, the
inhibitory power of constituents was studied by exerting
enzyme  to  amarogentin,  isovitexin   and   gentiopicroside  in
the concentration range from 1×10G7 to 3×10G4 M in the
standard enzyme assay. That concentration range was  chosen
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Fig. 4(a-b): (a)  E-NTPDase  activity  in  the  presence  of  amarogentin  (squares),  isovitexin  (circles)  and  gentiopicriside (triangles)
in rat synaptic  plasma  membranes.  The  values  given  are  the  mean  of  at  least  three  experiments±SEM
performed in duplicate and (b) Inhibition curves of high affinity E-NTPDase isoform. Inset: Hill analysis of inhibition
curves
based  on  constituent’s  abundance in  extracts (Table 2)
present  in  200  µg  of  extracts.  Based  on  results  obtained
with  enzyme  inhibition  in  a  time  dependent  manner,  it
was   determined   that   the   optimal   time   of   inhibition   of
the  E-NTPDase  with  all  inhibitors,  separately  was  20 min.
The  experimental  points,  that  represent  the percent  of
retained  activity   compared  to  the  control  (Fig. 4a)
indicated   that     there     was     the     biphasic     response    of
278
Int. J. Pharmacol., 12 (4): 272-289, 2016
30
20
10
0
In
hi
bi
tio
n 
(c
on
tro
l p
er
ce
nt
ag
e)
50 G+I+A G+A I+A G+A
Mixture combination (C  = 20 µg mL )G, I,  A G1
enzyme to all selected  compounds.  Briefly,  the certain
degree of enzyme activity inhibition (about 35%) was
achieved  in  the  concentration  range  which  spanned over
10G6 to 10G4 M, since by the further increasing of inhibitors
concentration the enzymatic activity reminded constant
(about 65% of control). Moreover, the inhibition curves
overlapped, indicating the similar dose response of the
investigated compounds to the enzyme. It is worth to notice
that the enzyme activity in the presence of higher inhibitors
concentration was not studied because of their low solubility
in water.
It is clear from the experimental results that the activity
versus constituent’s  concentration  plots  in  all  cases   can  be
represented by the sum of the sigmoid curve and a plateau. In
the mathematical analysis of the results presented in Fig. 4a.
It was assumed that the mass action principles were fully
satisfied and that the plot of  the  total  activity  represents  the
line for “Two enzymes acting on one substrate” (Krstic et al.,
2004; Vasic et al., 1999). The theoretical curves for high affinity
enzyme isoforms were obtained by subtracting the values of
the plateau from the experimental data and are presented in
Fig. 4b. They were fitted by sigmoid function. Moreover, Hill
analysis  was  performed  on  the   high   affinity   parts   of   the
inhibition curves (Fig. 4b) inset. The values of the Hill
coefficient n, determined by Hill analysis of the inhibition
curves  are   summarized   in   Table   3,    together   with  the
IC50 values  obtained   by   fitting   the  constructed inhibition
curves with sigmoid function. The Hill analysis always yielded
n>1, suggesting the cooperative binding of the inhibitor.
Using the calculated IC50  values, the total activity was
recalculated and presented in Fig. 4a as a solid curve. The
results show that an excellent fit of the experimental points
was obtained.
Since all of the tested constituents exerted a similar level
of inhibition, it was desirable to determine how they inhibit
enzyme when they are present together, like in extracts. For
this reason, mixtures of mentioned constituents, which
contain gentiopicroside, isovitexin and amarogentin in four
different combinations were prepared as it is  shown  in  the
Fig. 5.
The  highest   degree   of   inhibition,   about   16%   was
achieved with the mixture containing gentiopicroside,
isovitexin  and  amarogentin,  each  in  final  concentration   of
20 µg mLG1 (Table 4). All other mixtures, containing two
constituents (concentration in the mixtures, 20 µg mLG1)
inhibited  enzyme   to   lower   extent  (10,  5  and  3%).
However,  inhibition    of     E-NTPDase    achieved   with   single
Fig. 5: Inhibition of E-NTPDase with mixtures of constituents
(constituent’s names in the mixture are indicated by
their initial letters). The results present the mean values
obtained from two experiments performed in duplicate
Table 3: Parameters of E-NTPDase inhibition induced by amarogentin, isovitexin
and gentiopicroside
Sigmoid curve Hill analysis
Compound IC50  (M) p* IC50  (M) n** IC50  (µg mLG1)
Amarogentin 9.89×10G6 1.12 (1.02×10G5) 1.04 5.79
Isovitexin 1.13×10G5 1.45 (1.17×10G5) 1.31 4.88
Gentiopicroside 2.15×10G5 1.35 (1.95×10G5) 1.48 7.66
*Parameter of sigmoid function and **Hill coefficient
Table 4: E-NTPDase activity in the presence of constituents and their mixtures
(constituent’s names in the mixture are indicated by their initial letters)
All experiments were done in duplicate and results are expressed as
Mean±SD
E-NTPDase activity
Inhibitor Concentration (µM)* (Inhibition control percentage)
Gentiopicroside (G) 56 70.7 (29.3±1.2)
Isovitexin (I) 46 71.5 (28.5±0.8)
Amarogentin (A) 34 74.7 (25.3±1.8)
I (G+I+A) 56+46+34 84.5 (15.5±3.4)
II (G+I) 56+46 90.2 (9.8±0.2)
III (G+A) 56+34 97.0 (3.0±1.2)
IV (I+A) 46+34 94.7 (5.3±0.9)
*C = 20 µg mLG1 for each constituents individually and in the mixtures
constituents at   the  same  concentration  was 29.30, 28.5 and
25.30% for gentiopicroside,  isovitexin  and  amarogentin,
respectively. Comparison of  these  results  with  those
obtained from the inhibition curves leads to the conclusion
that these three constituents exhibit antagonistic effects when
they are present in the mixture in the same mass
concentration.
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Therefore, results obtained with mixtures of constituents
cannot explain higher inhibition (more than 50%) of tested
extracts. However, the possible explanations could be given
according  to  concentration  of  constituents  in tested
extracts (Table 2).  Namely,  in  the  inhibition  experiments
with single constituents, the lowest concentration for all
tested  constituents was  5  µg  mLG1 (molar concentration
range  from  8×10G6  to 1.2×10G5 M).  At  that  concentration
gentiopicroside,  isovitexin  and   amarogentin  exerted
inhibition of 18.0,  14.9  and 8.7%,   respectively.   It   is  obvious 
that only 200 µg of water and 50%  ethanol  extract,  contain 
5 µg mLG1 gentiopicroside. Concentration of isovitexin and
amarogentin in 200 µg of these extracts are too low to inhibit
E-NTPDase.
Results obtained in experiment with single constituents,
clearly indicate that there was no E-NTPDase inhibition in the
molar concentration range from 10G9 to 10G7 M. Despite that,
extracts in a concentration of 200 µg mLG1 inhibit E-NTPDase
in the range of 36-52%. That degree of inhibition is obviously
the  result  of  synergistic  effect  of   gentiopicroside  with
other constituents present in  G.  lutea   extracts.  They  include
swertiamarin and sweroside, which belongs to secoiridoid
class of compounds  and  isogentisin and gentisin belonging
to xanthones class of compounds. Otherwise, isogentisin were
found only in 50 and 75% ethanol water extracts. Thus, it
could be proposed  that isogentisin  significantly  contribute
to the inhibitory acitivity of ethanol water extracts and could
be a potentially strong inhibitor of E-NTPDase.
Molecular docking study: Therefore, the molecular docking
study with isogenitisin as inhibitor and with  ATP as  substrates
of E-NTPDase was carried out. For this study, E-NTPDase
isoform 2 was chosen since it is the most closly related to cell
surface-located NTPDase3 (Vorhoff et al., 2005). There is no
available crystal structure of E-NTPDase3 in the PDB database.
The E-NTPDase3 is the predominant isoform of ecto enzymes
displayed in rat SPM, followed with isoforms 2 and 1. Analysis
of the docking results predicted only one potent binding site
for isogentisin on E-NTPDase2 (Fig. 6) and this site overlaps
with binding site for ATP on enzyme (the nucleoside binding
site). These results indicate on the  competitive  inhibition  of
E-NTPDase2 enzyme. Estimated binding energy is slightly
greater  for  ATP  (-9.3  kcal  molG1)  comparing  to  isogentisin
(-8.0 kcal molG1). The reason for the energy differences
probably is a greater number of hydrogen bonds between ATP
and amino-acid residues of enzyme (Gly 47, Ser 48, Ala 123,
Gly 124, Gly  204,  Ala  205  and  Val  434)  than  the  number of
hydrogen bonds between  isogentisin  and  enzyme  (Ser 48,
Thr 122, Gly 204 and Trp 436) (Fig. 6). However, the binding of
isogentisin to the active site of the enzyme, despite  the  lower
binding energy than ATP can be explained by smaller size of
isogentisin and almost planar structure that enables its greater
mobility, compared to ATP molecule.
Docking studies with amarogentin, gentiopicroside,
isovitexin and loganic acid as inhibitors of E-NTPDase were
also carried out. The results indicate on the competitive
inhibition, because the studies showed only one potent
binding   site   for   amarogetin,   gentiopicroside,   isovitexin
and loganic  acid   on  E-NTPDase2  (Supplementary   material,
Fig. S1-S8), which overlaps with binding site for ATP on
enzyme.  Estimated   binding   energies   (Table   5)  are greater
for    amarogentin       (-9.4     kcal     molG1),      gentiopicroside
(-8.5  kcal  molG1),  isovitexin  (-9.4  kcal molG1)  and  loganic 
acid      (-8.6     kcal     molG1)      comparing      to       isogentisin
(-8.0 kcal molG1). The binding energy differences can be
explained by differences in the size of inhibitors (isogentisin,
amarogentin, gentiopicroside, isovitexin and loganic acid) and
by differences in the nature and number of interactions
between  inhibitor  and  amino-acid   residues   of  enzyme.   In
comparison with isogentisin, amarogentin, gentiopicroside
and loganic acid form a greater number of non-covalent
interactions with amino-acid  residues  of  enzyme 
(Supplementary  material, Fig. S3-S8). It known that hydrogen
bonds make a favorable contribution  to  protein stability
(Pace  et  al., 2014).  Figure  6 and 7 illustrate the hydrogen
bonds in the most stable cluster of inhibitor and E-NTPDase2
enzyme. One can conclude that there are also a greater
number of  hydrogen  bonds  between amino-acid residues of
enzyme   and   amarogentin, gentiopicroside, isovitexin and
loganic acid (Fig. 7) than a number of hydrogen bonds 
between  enzyme  and isogentisin (Fig. 6). Despite the fact
that the binding of amarogetin,  gentiopicroside,  isovitexin 
and  loganic  acid to the  active  site  seems  like  more
sterically    hindered   than  the  binding  of  planar   isogentisin
Table 5: Binding energies of isogentisin, amarogetin, gentiopicroside, isovitexin
and loganic acid as inhibitors of E-NTPDase and for ATP as a substrate of
E-NTPDase
Ligand Binding energy (kcal molG1)
ATP -9.3
Isogenitisin -8.0
Isogenitisin (dimer) -10.0
Amarogetin -9.4
Isovitexin -9.4
Gentiopicroside -8.5
Loganic acid -8.6
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Fig. 6(a-c): (a) Binding sites of ATP,  (b) Monomeric structure of isogentisin and (c) Dimeric structure of isogentisin at rat NTPDase2
enzyme. Hydrogen bonds of monomeric isogentisin with Ser 48, Thr 122, Gly 204 and Trp 436 residues are depicted
in the middle by red dotted lines
Fig. 7(a-d): Hydrogen bonds of (a) Amarogetin, (b) Gentiopicroside, (c) Isovitexin and (d) loganic acid in most stable cluster of
inhibitor and E-NTPDase2 enzyme. Hydrogen bonds are depicted by green line
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molecule, the higher flexibility of these three inhibitors
(expressed by a larger number of rotatable bonds) is in favor
of their stronger binding.
The second possible manner for  binding  of isogentisin
on NTPDase2 was found by analyzing  crystal  structures 
archived in the PDB. In  both  of  the  two  crystal structures
(PDB codes: 4CD1  and  4CD3)   the  sulfoanthraquinone 
inhibitor  PSB-071 (structurally similar to isogentisin) binds as
a sandwich of two molecules at the nucleoside binding site
(Trott and Olson, 2010). 
DISCUSSION
Gentiopicroside is the most abundant secoiridoid
constituents in the G. lutea  herb but its concentration
depends on extraction preparation procedure. Thus, the
extracts obtained  with  alcohol  water  mixtures, where
ethanol  is  present  in  volume  concentration  of  about  50%
or higher, yield the highest abundance of gentiopicroside
(Arino et al., 1997). However, extraction with boiling water
contributes that extraction   of   gentiopicroside   approaches 
or   surpass   those  obtained  with  alcohol  water  mixtures.
Also, extraction of loganic acid with water yielding to its
highest content in  tested  extracts. Eventhough amarogentin
was  proved   as   the   most   potent  inhibitor  of  E-NTPDase,
its  abundance in  extract  is  much lower and its presence
could be detected occasionally in G.  lutea  species, varying
from 0.03 to more than 0.3%, depending  on  its  origin  and
root processing method (Azman et al., 2014;  Aiello et al.,
2013).
Therefore, it could be proposed that increased inhibitory
activity of extracts toward E-NTPDase could  be  attributted  to
other constituents. That hypotesis  was  also  supported  with
E-NTPDase inhibition assay performed with mixtures of
constituents. Even present in higher concentration than in
extracts,   amarogentin,   isovitexin     and   gentiopicroside    in
mixtures did not achieve inhibition as each extract alone.
Other pharmacologically relevant constituents  present  in  the
extracts are swertiamarin, sweroside and secoiridoids with
similar structure as gentiopicroside. The abundance of these
compounds  is  in  the  range  from  0.2-0.4%  for  sweroside
and swertiamarin and from 0.02-0.11% for gentisin and
isogentisin which belong to  xanthones class of compounds.
There are also  present  other  xanthones  such  as  gentioside,
gentisin-1-O-   primaveroside.   Of   other  consituents  there
are  volatile   oils,   in   the   concentration  up  to  0.2%  and
carbohydrates,  mono,  di  and   tri   saccharides  (EMA.,  2009).
Based on concentration of gentiopicroside in all tested
extracts,  ranging  from  0.9-2.5%  and  corresponding
inhibition  of  E-NTPDase  from  36-52%, it can  be  concluded
that inhibition depends on the increased concentration of
gentiopicroside. 
However, 75% ethanol water extract contains lower
quanitiy of gentiopicroside  than  water  and 50% ethanol
water extracts but still inhibits E-NTPDase  stronger than
water. It is obvious that other compounds present in ethanol
water extracts, contribute (probably synergistically) to
stronger  inhibition   of   enzyme.   Since,   all  constituents  of
G. lutea  did not tested in vitro, the molecular docking study
was performed with a special emphasis on isogentisin.
According to results obtained with extracts it was
hypothesized that isogentisin significantly contributes to
inhibition of E-NTPDase.
The  results  of  docking  study  coincide with  those
obtained  experimentally  because   amarogentin   is   proved
to  be  most  potent  inhibitor  both  in  inhibition  assay  with
E-NTPDase and in  docking  study.  Namely,  the  binding
energy of amarogentin is -9.4 kcal molG1, while IC50 = 9.89  µM.
Binding energy for isovitexin is the same as for amarogentin
but experimentally determined IC50 of isovitexin is 11.3 µM.
Gentiopicroside binding energy is -8.5 kcal molG1 and thus
determined IC50 is higher, i.e., 21.5 µM. Loganic acid, which
was  excluded  in  our  preliminary   experiment,   because  it
did not  show  inhibition  at  investigated concentration has
the binding energy as gentiopicroside. Finally, results of
molecular   docking   study   of   isogentisin  showed  the
lowest binding energy  in  comparison with other constituents
(-8.0 kcal molG1). However, isogentisin dimer binds  at  the
same site as isogentisin monomer and ATP (Fig. 6) but with
greater binding energy (-10.0 kcal molG1, Table 5). Better
binding of dimeric structure to the active site is important but
not decisive for inhibitory activity, because the approach of
the dimeric structure to the active site is more sterically
hindered than the approach of monomer or of ATP to the
active site. However, the binding of isogentisin to the active
site of the enzyme, despite the lower binding  energy  than
ATP can be explained by the smaller size of isogentisin and its
almost planar structure that enables its greater mobility,
compared to the ATP molecule. 
Even though,  there  are  two  possible  explanations
about the inhibition of E-NTPDase with isogentisin, its
structure  indicates  that  it  could  be  potential  inhibitor  of
this  enzyme.   Namely,   in   addition   to  the  structure
similarity   with   sulfoanthraquinone,    there   are   also   found
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similarity   with reactiv blue 2 (sulfonated dyes) structure
(Muller  et  al.,  2006;  Al  Rashida  and  Iqbal,  2014).  In  the
study performed with the ADP induced platelet aggregation,
it was shown inhibition of aggregation with xanthones
derivates (Rajtar et al., 1999). Although platelets contain
membrane’s E-NTPDase isoformes in different proportion then
synaptosomes, that finding supports hypothesis proposed in
this study. 
When considering other class of compounds as inhibitors,
it was shown in previous studies, that nonselective NTPDase
inhibitors achieve 25% of inhibition in the concentration range
between 17-62 µM for cibacron blue,  uniblue  and  mentioned
reactive blue as well as aromatic isothiocyanato sulfonates in
the concentration range from 10 to 464 µM (Al Rashida and
Iqbal, 2014). In the recent study, which was comprised the
screening of 438 structurally diverse drugs it was proposed
that  compounds  which  show  at  least  30%  of  inhibition  at
20 µM  concentration  should  be  considered  as hit
compounds  (Fiene et  al.,  2015).  In  fact compounds  that
have proven  to  be  potent  inhibitors  of  these  enzymes
belong  to  the  polyoxometalate  class  of compounds, with
IC50  in  the  range   from  1.7-3.4  for   12-tungstosillicid acid
and  12-tungstophosphoric  acid (Colovic et al.,  2011). Thus,
considering G.  lutea  constituents in any of proposed manner,
one can conclude that they are promising candidate for
inhibitor  development  since  their  IC50  is  in  the   range  of
10-20 µM. On the other hand, there are no sufficient data
about inhibition of E-NTPDase with herbal extract, so far.
However, it was found out in a recent study, that six plant
extracts, among fifty tested, exert a significant level of
inhibition, above 50%, toward E-NTPDase present in the crude
enzyme preparation of chicken liver (Ashraf et al., 2011). This
type of E-NTPDase found in liver, bone and kidney is tissue
nonspecific AP with affinity toward various monoesters of
phoshoric acid. The difference from those E-NTPDase present
in the rat synaptosomal membrane (type 3) is different affinity
toward ATP as well as its final products.
Plant  extracts  exerting  inhibitory  activity  toward  liver
E-NTPDase belong to Lilliaceae, Asteraceae and Apiaceae
family of herbs and all of them inhibited E-NTPDase at the
concentration of 125 µg mLG1 in the range from 51% to
approximately  58%.  Among  them  the  best   inhibition   was
achieved  with   Asparagus   officinalis   methanolic  extract,
with  an  inhibition  of  58.24%   toward   E-NTPDase   which  is
comparable with inhibition achieved with G. lutea  extracts,
with an inhibition of 52.89% at concentration of 200 µg mLG1
(50% ethanol aqueous). The  results  obtained  in  both  studies
could be of interest, since E-NTPDases expressed in various
tissues show different affinity toward ATP and ADP, thus it is
quite possible to expect some differences in inhibition
(Zimmermann, 2001). For instance, inhibition of E-NTPDase
present on human lymphocytes belonging to CD39 family
(isoform 1) has pro-immflamatory effects (Chadwick and
Frischauf, 1998).
Significance of results obtained using rat’s synaptosomal
membranes   as    a     model    system    for    investigation    of
E-NTPDase activity in the presence of G. lutea  extracts is
according to role of ATP in the brain, where it acts as a rapid
neurotransmitter. There, ATP binds to the P2X purinoceptor,
a ligand-gated ion channel and its action is related to
demyelination and remyelination of axons, termination of
purinergic signaling and development of neurones. Any
variation from its physiological concentrations may cause
adverse effects. It was found, in the human actively spiking
regions, that the activities of synaptosomal E-NTPDase are
decreased. Hence, an additional inhibition of this enzyme,
with inhibitors, like herbal  preparations, may cause
hyperactivity and increased excitability in the epileptic brain
(Horvat et al., 2006).
CONCLUSION
Results  demonstrate  that G.  lutea   extracts  are  potent
E-NTPDase  inhibitors.  The   highest   level   of   inhibition
(about 50%) was achieved with ethanol water extracts in a
concentration of 200 mg mLG1. The constituents shown
approximately the same level of inhibition with IC50 ranging
from 1 to 2×10G5 M. The results of molecular docking study
are identified gentiopicroside, amarogentin, isovitexin and
isogentisin dimer as potential enzyme inhibitors with binding
energies slightly greater than for ATP. These results could be
useful for the evaluation of the safety of herbal preparations,
particularly those belonging to the Gentianaceae family of
herbs. Furthermore, compounds related to secoiridoids and
xanthones class of compounds could be examined as
potential enzyme inhibitors.
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SUPPLEMENTARY MATERIALS
Fig. S1(a-b): (a) UPLC/PDA chromatograms and extracted absorption spectra of G. lutea  constituent's mixtures (C = 100 µg mLG1)
with  loganic  acid  (Rt  =  2.88),  gentiopicroside  (Rt = 3.67),  isovitexin (Rt = 4.87)  and amarogentin (Rt = 6.43)  and
(b) Chromatogram of 75% ethanol water extract (C = 10 mg mLG1) and absorption spectra of its constituents with
isogentisin at Rt = 9.96 min. Isogentisin (from 50 and 75% ethanol water extract) spectrum with absorption maxima
at 238.2, 259.0, 308.9 and 372.8, already confirmed in the previous study (Morimoto at al., 1983)
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Fig. S2(a-b): TIC chromatograms of water, 25, 50 and 75 ethanol water extracts in (a) ESI negative MRM mode with characteristic
precursor  and  product  ions  for  gentiopicroside  (Rt = 3.71),  isovitexin  (Rt = 5.03), amarogentin  (Rt  = 6.59)  and
(b) ESI positive MRM mode with loganic acid (Rt = 3.0) and isogentisin (Rt = 10.11). Mass chromatograms and spectra
were recorded and processed using MassLynx NT software (version 4.1)
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Fig. S3: Binding site and binding energies for nine most stable cluster of amarogetin and E-NTPDase2 enzyme
Fig. S4: Structure of amarogentin (displayed by green wireframe style) and amino acid residues in most stable cluster of
amarogetin and E-NTPDase2 enzyme (Gln 71, Ala 437, Ala 433, Val 434, Lys 428, Lys 427, Gly 435, Trp 436, Ser 346, Tyr 350,
Glu 165, Gly 203, Gly 204, Ala 205, Arg 245, Phe 54, Asp 76, Ser 52, Asp 45, His 50, Gly 47, Ser 49, Ser 48 and Thr 122)
Fig. S5: Binding site and binding energies for nine most stable cluster of gentiopicroside and E-NTPDase2 enzyme
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Fig. S6: Structure of gentiopicroside (displayed by green wireframe style) and amino acid residues in most stable cluster of
gentiopicroside andE-NTPDase2  enzyme (Gly 204, Gly 203, Ala  205,  Asp 246, Arg 245, Ser 346, Val 434, Ala 433, Ser 48,
Ser 49, Ala 123, Gly 124, Gly 47, His 50, Thr 122, Asp 45, Glu 165, Ser 52, Trp 436 and Ser 346)
Fig. S7: Binding site and binding energies for nine most stable cluster of loganic acid and E-NTPDase2 enzyme
Fig. S8: Structure of loganic acid (displayed by green wireframe style) and amino acid residues in most stable cluster of loganic
acid  and  E-NTPDase2  enzyme  (Ala  123,  Ala  205, Thr 122, Gly 204, Gly 203, Glu 165, Arg 245, Ala 437, Trp 436, Gly 435,
Ser 346, Val 434, Tyr 350, Ala 433, Lys 427, Ser 48, Ser 49, Gly 47, His 50, Asp 45, Ser 52 and Phe 54)
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